WikiTrademarks - Search, analyse, and monitor trademark applications.

Trademark: PERSONALIZED MEDICINE IN HEMATOLOGY/ONCOLOGY

Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io

Tweet this

Track updates on PERSONALIZED MEDICINE IN HEMATOLOGY/ONCOLOGY

Mark Identification

Proof of use for PERSONALIZED MEDICINE IN HEMATOLOGY/ONCOLOGY

We do not have any records of a proof of use for PERSONALIZED MEDICINE IN HEMATOLOGY/ONCOLOGY at this moment.

Click here to add a proof of use for PERSONALIZED MEDICINE IN HEMATOLOGY/ONCOLOGY

Possible trademark infringements of PERSONALIZED MEDICINE IN HEMATOLOGY/ONCOLOGY

Basic Information about PERSONALIZED MEDICINE IN HEMATOLOGY/ONCOLOGY

Serial Number
85263844
Filing Date
10 Mar 2011
Mark Drawing Code
4

Classifications

Declare the trademark use of PERSONALIZED MEDICINE IN HEMATOLOGY/ONCOLOGY on the blockchain with WikiTrademarks.io.

First use of PERSONALIZED MEDICINE IN HEMATOLOGY/ONCOLOGY anywhere
PERSONALIZED MEDICINE IN HEMATOLOGY/ONCOLOGY was first used on 31 Dec 2010 for the primary classification of goods and services, international, 041 (Education and entertainment)
First use in commerce
There is no first use of this trademark in commerce detected yet.
Status Code
6
International Code
041
US Codes
100; 101; 107

Who owns PERSONALIZED MEDICINE IN HEMATOLOGY/ONCOLOGY?

1. THE LYNX GROUP, LLC CRANBURY NJ

Correspondent

Brian L. Petrequin, Esq.
Greenberg Traurig, LLP
500 Campus Drive, Suite 400
Florham Park NJ 07932

Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io

Tweet this

Track updates on PERSONALIZED MEDICINE IN HEMATOLOGY/ONCOLOGY